Clinical trials recruiting in Tlajomulco de Zúñiga, Mexico

Phase breakdown

Conditions recruiting in Tlajomulco de Zúñiga, Mexico

Recruiting trials in Tlajomulco de Zúñiga, Mexico

• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
  NCT07012395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
  NCT06979336 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Vagal Stimulation Therapy and Preeclampsia
  NCT06953115 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female

Common questions

How many clinical trials are recruiting in Tlajomulco de Zúñiga, Mexico?

5 recruiting trials have at least one study site in Tlajomulco de Zúñiga, Mexico.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.